Remicade (infliximab) - J&J
Bimzelx (bimekizumab-bkzx) - UCB
Humira (adalimumab) - AbbVie
Cosentyx (secukinumab) - Novartis
https://eppro02.ativ.me/web/page.php?page=IntHtml&project=SID2026&id=4496863
 
Simona A. Alomary* 1,3; Nicole Baker 2; Temitayo Ogunleye 3; Susan C. Taylor 3
 
May 18, 2026
 
Prev Next